Gui Pi Tang

Gui Pi Tang (归脾汤, Guī Pí Tāng) is a classical Chinese herbal formula first recorded in the Ji Sheng Fang (济生方, Prescriptions for Saving Lives) by Yan Yonghe (严用和, 1253 CE) during the Southern Song dynasty. The formula name literally translates to “Restore the Spleen Decoction” — Gui (归) means to return or restore, and Pi (脾) refers to the Spleen. Tang (汤) denotes a decoction, indicating the herbs are boiled together in water to produce a liquid extract. The name reflects the formula's primary therapeutic strategy: restoring the Spleen to its proper function so that it can adequately produce Qi and Blood to nourish the body.

In the TCM classification system, Gui Pi Tang belongs to the category of tonifying formulas (bu yi ji, 补益剂), specifically within the subcategory of Blood-tonifying formulas (bu xue ji, 补血剂). Its therapeutic strategy encompasses three interconnected actions: tonifying Qi (bu qi, 补气) to address the root of Blood deficiency, nourishing Blood (yang xue, 养血) to treat the deficiency directly, and calming the Spirit (an shen, 安神) to address the mental-emotional manifestations of Heart Blood insufficiency. This triple action targets the classic pathological interplay between Spleen Qi deficiency and Heart Blood deficiency — a pattern that manifests with both physical symptoms (fatigue, pallor, poor appetite) and mental-emotional symptoms (palpitations, insomnia, poor memory, anxiety).

Within TCM education, Gui Pi Tang is considered a paradigmatic formula for understanding the classical principle of “treating both Spleen and Heart simultaneously” (xin pi tong tiao, 心脾同调). The physiological rationale is that the Spleen is the source of Qi and Blood production, while the Heart governs Blood circulation and houses the Spirit (Shen, 神). When Spleen Qi is deficient, Blood production declines, leading to Heart Blood insufficiency. The Heart, deprived of adequate Blood nourishment, cannot properly anchor the Spirit, resulting in insomnia, palpitations, and mental restlessness. Gui Pi Tang addresses this chain of pathology by strengthening the Spleen at its root while directly nourishing the Heart and calming the Spirit at the level of manifestation.

In modern TCM clinical practice, the formula is frequently discussed in the context of neuropsychiatric conditions — including insomnia, anxiety, depression, and chronic fatigue syndrome — as well as hematological conditions such as chronic idiopathic thrombocytopenic purpura (ITP) and functional uterine bleeding, all understood through the lens of Heart-Spleen Qi-Blood deficiency. It is important to note that these correspondences between TCM patterns and modern biomedical conditions are conceptual analogies, not equivalences. Modern clinical research on this formula, while growing, remains limited and does not establish efficacy for any specific condition.

Yan Yonghe (严用和, c. 1200–1265 CE) was a prominent physician of the Southern Song dynasty (1127–1279 CE). His Ji Sheng Fang (济生方, Prescriptions for Saving Lives), completed in 1253 CE, is one of the most important formularies of the Song period. The work is notable for its systematic organization of prescriptions by clinical indication and its emphasis on modifying classical formulas to suit individual patient presentations. Yan Yonghe's approach reflected the broader Song dynasty trend toward practical, clinically oriented medical writing that synthesized earlier theoretical frameworks with empirical therapeutic innovations.

The original Ji Sheng Fang version of Gui Pi Tang contained a somewhat different composition from the formula commonly used today. The original formula included Ren Shen (ginseng), Huang Qi, Dang Gui, Long Yan Rou, Suan Zao Ren, Fu Ling, Mu Xiang, Gan Cao, and Sheng Jiang — but notably lacked Bai Zhu, Yuan Zhi, and Da Zao. This version was primarily designed to strengthen the Spleen and nourish the Heart for the pattern of Spleen and Heart deficiency.

The formula received its most influential revision from Xue Ji (薛己, 1487–1559 CE), a distinguished physician of the Ming dynasty (1368–1644 CE), in his Zheng Ti Lei Yao (正体类要, Classified Essentials of Traumatology), published in 1529 CE. Xue Ji added Bai Zhu (to strengthen the Spleen), Yuan Zhi (to calm the Heart and open the orifices), and Da Zao (to nourish Blood and harmonize). This twelve-herb composition became the standard version that is taught in TCM textbooks today. Xue Ji's contribution illustrates the classical practice of formula evolution, where later physicians refine earlier compositions based on expanded clinical experience and deeper theoretical understanding.

Subsequent generations of physicians further expanded upon the formula's theoretical framework. During the Qing dynasty (1644–1912 CE), Chen Shiduo (陈士铎) discussed Gui Pi Tang extensively in his Shi Shi Mi Lu (石室秘录, Secret Records of the Stone Chamber), elaborating its application for conditions involving both mental and physical manifestations of deficiency. Wang Kentang (王肯堂), in his Zheng Zhi Zhun Sheng (证治准绳, Standards for Diagnosis and Treatment), included Gui Pi Tang as a core formula for the treatment of Spleen failing to govern Blood, thereby expanding its classical indications to include chronic bleeding disorders.

In Japan, Gui Pi Tang (called Kihito in Japanese Kampo, 帰脾湯) has been adopted into clinical practice and is manufactured by several Kampo pharmaceutical companies including TSUMURA & Co. Japanese clinical research on the formula — particularly for conditions related to autonomic nervous system dysfunction, anemia, insomnia, and chronic fatigue — represents a significant body of modern evidence that complements Chinese clinical studies. This cross-cultural adoption underscores the formula's enduring clinical relevance across East Asian medical traditions spanning over seven centuries.

The following composition reflects the standardized twelve-herb version from Xue Ji's Zheng Ti Lei Yao (1529 CE). Specific dosages are not provided as they vary by historical source and individual context. This is not a dosage recommendation.

The formula reflects the classical strategy of simultaneously tonifying Qi and nourishing Blood while calming the Spirit — the principle of “treating both Spleen and Heart simultaneously” (xin pi tong tiao, 心脾同调). The inclusion of Mu Xiang adds a Qi-moving component, preventing the rich tonifying herbs from causing stagnation.

Formula Explanation (Fang Jie, 方解)

The architectural logic of Gui Pi Tang can be understood through four functional herb groups operating in concert:

• Dang Shen (党参) / Ren Shen (人参) + Huang Qi (黄芪) — Qi-Tonifying Emperor Pair. Dang Shen (or Ren Shen in the original formulation) strongly tonifies Spleen Qi, addressing the root of both Qi and Blood deficiency since the Spleen is the source of Blood production. Huang Qi tonifies Qi, raises Yang, and has the additional important function of consolidating the exterior and preventing leakage of fluids and Blood — making it particularly valuable when the formula is used for the Spleen-failing-to-govern-Blood pattern. Together, they form the Emperor herb group that drives the overall tonifying action of the formula.
• Dang Gui (当归) + Long Yan Rou (龙眼肉) — Blood-Nourishing Minister Pair. Dang Gui is the chief herb for nourishing Blood and harmonizing Blood vessels. Long Yan Rou (Arillus Longan) is a sweet, warm herb that specifically nourishes Heart Blood and calms the Spirit. In TCM, Long Yan Rou is considered one of the premier herbs for simultaneously addressing both the Spleen (by tonifying Qi and Blood) and the Heart (by nourishing Heart Blood and calming the Spirit). Together, they directly address Blood deficiency at both the Spleen (production) and Heart (governance) levels.
• Bai Zhu (白术) + Fu Ling (茯苓) + Suan Zao Ren (酸枣仁) + Yuan Zhi (远志) — Spleen-Strengthening and Spirit-Calming Assistant Group. Bai Zhu strengthens the Spleen and dries Dampness, supporting the Qi-tonifying action of the Emperor herbs. Fu Ling strengthens the Spleen, drains Dampness, and additionally calms the Spirit — serving as a bridge between the Spleen-strengthening and Heart-nourishing functions. Suan Zao Ren nourishes Heart Blood and Yin, and is one of the most important herbs in TCM for treating insomnia by calming the Spirit. Yuan Zhi communicates with the Heart, calms the Spirit, and opens the orifices; it is particularly useful when Heart Blood deficiency causes poor memory and difficulty concentrating. Together, these four herbs create a comprehensive Spleen-Heart support system.
• Mu Xiang (木香) + Gan Cao (甘草) + Sheng Jiang (生姜) + Da Zao (大枣) — Harmonizing and Regulating Group. Mu Xiang is a critically important herb in this formula's architecture: it moves Qi and regulates the Spleen and Stomach, preventing the rich tonifying herbs from causing Qi stagnation and abdominal distension. This reflects the sophisticated principle of “tonifying without stagnating” (bu er bu zhi, 补而不滞). Gan Cao harmonizes all the ingredients and tonifies Spleen Qi. Sheng Jiang warms the middle and harmonizes the Stomach. Da Zao nourishes Blood and tonifies the Spleen while harmonizing the formula.

The overall therapeutic strategy can be summarized as “tonifying both Qi and Blood” (qi shuang bu, 气血双补) while “treating both Spleen and Heart simultaneously” (xin pi tong tiao, 心脾同调). This elegant approach — strengthening the Spleen (the source) to produce Blood, nourishing the Heart (the destination) to house the Spirit, and regulating Qi flow (via Mu Xiang) to prevent stagnation from the tonifying herbs — exemplifies the sophisticated clinical reasoning of the Song-Ming dynasty formulators and remains one of the most frequently prescribed formulas in modern TCM practice.

These are traditional TCM pattern descriptions, not modern medical diagnoses. They do not constitute treatment recommendations.

• Heart and Spleen Qi and Blood Deficiency (心脾两虚) — The primary pattern for which this formula is classically discussed. Symptoms traditionally associated with this pattern include palpitations, insomnia, poor memory, fatigue, pallor, poor appetite, and loose stools. The mental-emotional symptoms arise because Heart Blood deficiency fails to anchor the Spirit (Shen), while the physical symptoms reflect Spleen Qi deficiency. On examination, the tongue is typically pale (she dan, 舌淡) with a thin white coating (bai tai, 白苔), and the pulse is characteristically fine and weak (xi ruo mai, 细弱脉), reflecting both Blood insufficiency (fine) and Qi deficiency (weak).
• Spleen Failing to Govern Blood (脾不统血) — A pattern in which weakened Spleen Qi cannot hold Blood within the vessels, leading to chronic bleeding. This may manifest as subcutaneous purpura, hematochezia (blood in stools), hematuria, abnormal uterine bleeding (metrorrhagia or menorrhagia), or prolonged menstrual flow. In addition to bleeding symptoms, patients typically present with signs of Spleen Qi deficiency: fatigue, pale complexion, poor appetite, and loose stools. The tongue is pale with teeth marks (ya yin, 齿痕), and the pulse is weak (ruo mai, 弱脉). Huang Qi in the formula plays a particularly important role in this pattern by tonifying Qi to consolidate the vessels and stop bleeding.
• Heart Blood Deficiency with Mental Restlessness (心血虚，神不守舍) — When Heart Blood deficiency becomes pronounced, the Spirit (Shen) loses its anchoring, leading to more prominent neuropsychiatric symptoms: severe insomnia, vivid dreaming, anxiety, irritability, poor concentration, and a feeling of inner restlessness. This pattern is often seen in chronic illness, post-convalescence, or prolonged mental strain. The tongue is pale, especially at the tip (reflecting Heart involvement), and the pulse is fine and rapid (xi shu mai, 细数脉) or fine-weak (xi ruo mai, 细弱脉). In this pattern, Suan Zao Ren and Yuan Zhi play especially important roles in calming the Spirit and anchoring the Heart.

Modern research on Gui Pi Tang has expanded over recent decades, with studies spanning preclinical pharmacology, small clinical trials, and epidemiological investigations. While the evidence base is growing, it remains largely preliminary. The following summaries reflect what individual studies have reported, not established clinical recommendations.

Level 1 — In Vitro and Animal Studies (Preclinical Foundation)

Preclinical research has identified several mechanisms potentially relevant to Gui Pi Tang's traditional indications. Studies on Huang Qi (Astragalus membranaceus) have demonstrated immunomodulatory effects, including enhancement of macrophage activity, stimulation of natural killer (NK) cell function, and regulation of T-cell subsets in animal models. Research on Suan Zao Ren (Ziziphus jujuba seed) has identified jujubosides and flavonoids with sedative and anxiolytic-like effects in rodent models, possibly mediated through GABAergic and serotonergic pathways. Yuan Zhi (Polygala tenuifolia) extract has shown neuroprotective effects in animal models, including improvement of memory and learning in aged rats. These findings, while biologically plausible, cannot be directly extrapolated to clinical effectiveness in humans.

Level 2 — Small Clinical Trials (Preliminary Human Data)

Several small randomized controlled trials, primarily conducted in China, have evaluated Gui Pi Tang and its modifications for various conditions. A systematic review by Wang et al. (2017), published in Journal of Traditional Chinese Medicine, evaluated Chinese herbal formulas for insomnia and found that Gui Pi Tang-based formulas showed potential improvements in sleep quality scores (measured by the Pittsburgh Sleep Quality Index), but the included studies were limited by small sample sizes (typically n = 40–80 per arm), inadequate blinding, and heterogeneous outcome measures. Other small trials have explored Gui Pi Tang for chronic fatigue syndrome, reporting improvements in fatigue severity scores, and for functional dyspepsia, noting symptom relief in patients with Spleen deficiency presentations. These results are suggestive but far from conclusive.

Level 3 — Systematic Reviews and Meta-Analyses (Synthesized Evidence)

A meta-analysis by Li et al. (2019), published in Evidence-Based Complementary and Alternative Medicine, evaluated Gui Pi Tang for the treatment of chronic idiopathic thrombocytopenic purpura (ITP) and reported that the formula, when combined with conventional therapy, showed potential for improving platelet counts compared to conventional therapy alone. However, the analysis was limited by the small number of included trials (fewer than 10), variable quality, and significant heterogeneity. Another systematic review by Zhang et al. (2020) assessed Gui Pi Tang for anxiety and depressive disorders, finding some evidence of benefit on symptom scales, but concluded that the evidence was insufficient to draw definitive conclusions due to methodological limitations including inadequate randomization, lack of allocation concealment, and short follow-up durations.

Level 4 — Clinical Practice Observations (Real-World Reports)

In Chinese and Japanese clinical practice, Gui Pi Tang is one of the most frequently prescribed formulas in outpatient TCM settings. Clinical observation series and case reports from China have documented its use for a wide range of conditions including insomnia, anxiety, depression, chronic fatigue, post-illness convalescence, functional uterine bleeding, and chronic gastritis. In Japanese Kampo practice, Kihito (the Japanese name for Gui Pi Tang) is commonly prescribed for neurovegetative symptoms, anemia-related fatigue, and autonomic dysfunction. While these clinical observations are valuable for generating hypotheses and identifying patterns of use, they do not constitute controlled evidence and are subject to significant selection bias, placebo effects, and the absence of control groups.

Overall Evidence Limitations

Key limitations of the existing evidence base include: most clinical studies were conducted in single centers in China with small sample sizes (typically n = 40–100); many studies used modified versions of the formula rather than the classical twelve-herb composition; blinding was often inadequate or absent; few studies compared the formula against established standard therapies; long-term safety data are absent; there is a lack of high-quality, large-scale systematic reviews and meta-analyses specifically focused on Gui Pi Tang; and the gap between preclinical pharmacological findings (often promising) and clinical evidence (often inconclusive) remains substantial. As a result, the evidence does not establish efficacy for any specific condition.